Cancer
Decoding Epigenetic Triggers: Unveiling the Mechanisms Driving Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC), the predominant form of primary liver cancer, persists as a formidable global health challenge due to its...
Salk Institute Scientist Deepshika Ramanan Honored as Rita Allen Foundation Scholar
In a groundbreaking announcement from the Salk Institute for Biological Studies, Assistant Professor Deepshika Ramanan has been honored as a...
Comprehensive Tumor DNA Analysis Implemented for Every Child at the Princess Máxima Center
In a landmark development in pediatric oncology, the Princess Máxima Center for pediatric oncology in Europe has pioneered the integration...
City of Hope Receives $23.7 Million Grant to Map Biomarkers of Treatment Resistance in Common Lung Cancer
City of Hope Secures Landmark $23.7 Million Grant to Revolutionize Immunotherapy Resistance in Non-Small Cell Lung Cancer In a groundbreaking...
Stanford Researchers Identify Missing Yew Tree Enzymes Crucial for Producing Common Cancer Drug
A Breakthrough in Taxol Biosynthesis: Unlocking the Enzymatic Blueprint for Scalable Cancer Drug Production Taxol, also known as paclitaxel, has...
Personalized Automated Nutrition Guidance for Cancer Patients Revolutionizes Care
In the evolving landscape of oncology care, nutrition has emerged as a crucial factor influencing the outcomes and quality of...
Discovery of Novel Fusion Gene Enables Accurate Diagnosis of Adenoid Cystic Carcinoma
A pioneering case study from the Fox Chase Cancer Center is shedding new light on the complex molecular underpinnings of...
Cardiac Biomarkers Predict Future Cancer Risk Independent of Heart Disease
A groundbreaking study led by researchers at UCLA Health has unveiled compelling evidence that bridges the long-assumed gap between cardiovascular...
Calibr-Skaggs Administers First Patient with Switchable CAR-T Cell Therapy in Phase 1 Trial Targeting Metastatic Breast Cancer
Revolutionizing Solid Tumor Treatment: The Dawn of Switchable CAR-T Therapy in Advanced Breast Cancer In a groundbreaking advancement poised to...
Bayesian Learning Enhances Accuracy in Gene Research
Researchers at The University of Texas at Arlington have introduced a groundbreaking computational tool designed to pinpoint transcriptional regulators—proteins responsible...
Rare Pancreatic Cancer Patients Exhibit Remarkable Response to Immunotherapy
In a groundbreaking study published in the June 2025 issue of Oncotarget, researchers from multiple U.S. institutions have reported a...
Insilico Medicine’s Chemistry42 Drives Discovery of Novel Chemotype Pan-KRAS Inhibitors – ACS Medicinal Chemistry Letters
In a significant breakthrough that harnesses the cutting-edge capabilities of artificial intelligence (AI) in drug discovery, Insilico Medicine, a leading...
UNF Researchers Near Breakthrough in Developing Drug to “Turn Off” Cancer Following Second Patent Approval
In a groundbreaking advancement that could redefine cancer treatment paradigms, researchers at the University of North Florida have secured a...
Emerging Immunotherapies Revolutionize Lung Cancer Treatment
In recent years, the landscape of lung cancer treatment has been dramatically reshaped by the introduction and widespread adoption of...
New Genetic Method Expands Access to Hereditary Breast and Ovarian Cancer Risk Testing for Women
A Breakthrough in Genetic Screening Offers New Hope for Families with Hereditary Cancer Risks For decades, the shadow of hereditary...
HKUMed Pioneers Global Liver Cancer Treatment with Innovative Dual Immunotherapy, Enhancing Patient Survival and Securing International Approvals
A groundbreaking advancement in the treatment of advanced hepatocellular carcinoma (HCC), the most common form of liver cancer, has emerged...
Colorectal Cancer Diagnosis: A Lifesaving Breakthrough or a New Threat for Patients with Multiple Cancers?
A groundbreaking study published in the Journal of the American College of Surgeons reveals a surprising twist in the prognosis...
Mount Sinai and Cancer Research Institute Collaborate to Enhance Immunotherapy Outcomes
In a groundbreaking alliance poised to redefine the landscape of cancer treatment, OCCAM Immune—a pioneering initiative under the Icahn School...
Breakthroughs in Science Unlock Treatments for the Most Challenging Bladder Cancers
In a groundbreaking study poised to reshape the therapeutic landscape of bladder cancer, researchers at the University of California, San...
Research Spotlight: Exploring the Survivorship Journey of Older Breast Cancer Patients
As the population of older adults continues to expand, the landscape of breast cancer survivorship is undergoing significant transformation. A...
